Elangovan A, Shah R, Ali SM, Katz J, Cooper GS. High burden of obesity and low rates of weight loss pharmacotherapy in inflammatory bowel disease: 10-year trend. Crohn’s & Colitis 360. 2023;5(2):otad007.
Efficacy of GLP-1 receptor agonists on obesity and metabolic profile in patients with inflammatory bowel disease: a systematic review and meta-analysis | BMC Gastroenterology
